Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.64 USD -2.94% Market Closed
Market Cap: 777.9m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Abcellera Biologics Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Abcellera Biologics Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
ARCH
RP
IOT

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Abcellera Biologics Inc
NASDAQ:ABCL
Cash & Cash Equivalents
$133.3m
CAGR 3-Years
-39%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Arch Biopartners Inc
XTSX:ARCH
Cash & Cash Equivalents
CA$44k
CAGR 3-Years
-11%
CAGR 5-Years
-45%
CAGR 10-Years
-13%
Replicel Life Sciences Inc
XTSX:RP
Cash & Cash Equivalents
CA$15.2k
CAGR 3-Years
-32%
CAGR 5-Years
-9%
CAGR 10-Years
-41%
Innovotech Inc
XTSX:IOT
Cash & Cash Equivalents
CA$120.5k
CAGR 3-Years
-41%
CAGR 5-Years
39%
CAGR 10-Years
6%

See Also

What is Abcellera Biologics Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
133.3m USD

Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Cash & Cash Equivalents amounts to 133.3m USD.

What is Abcellera Biologics Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
67%

Over the last year, the Cash & Cash Equivalents growth was -66%. The average annual Cash & Cash Equivalents growth rates for Abcellera Biologics Inc have been -39% over the past three years , 67% over the past five years .

Back to Top